Levosulpiridum_[Inn-Latin]

Category

Levosulpiridum_[Inn-Latin]




Useful info

Levosulpiridum_[Inn-Latin] Brand names, Levosulpiridum_[Inn-Latin] Analogs

Levosulpiridum_[Inn-Latin] Brand Names Mixture

  • No information avaliable

    • Levosulpiridum_[Inn-Latin] Chemical_Formula

    C15H23N3O4S

    Levosulpiridum_[Inn-Latin] RX_link

    No information avaliable

    Levosulpiridum_[Inn-Latin] fda sheet

    Levosulpiridum_[Inn-Latin] msds (material safety sheet)

    Levosulpiridum_[Inn-Latin] MSDS

    Levosulpiridum_[Inn-Latin] Synthesis Reference

    No information avaliable

    Levosulpiridum_[Inn-Latin] Molecular Weight

    341.427 g/mol

    Levosulpiridum_[Inn-Latin] Melting Point

    178 oC

    Levosulpiridum_[Inn-Latin] H2O Solubility

    2280 mg/L

    Levosulpiridum_[Inn-Latin] State

    Solid

    Levosulpiridum_[Inn-Latin] LogP

    1.337

    Levosulpiridum_[Inn-Latin] Dosage Forms

    Tablet

    Levosulpiridum_[Inn-Latin] Indication

    Sulpiride is indicated for the treatment of schizophrenia.

    Levosulpiridum_[Inn-Latin] Pharmacology

    Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.

    Levosulpiridum_[Inn-Latin] Absorption

    No information avaliable

    Levosulpiridum_[Inn-Latin] Toxicity

    No information avaliable

    Levosulpiridum_[Inn-Latin] Patient Information

    No information avaliable

    Levosulpiridum_[Inn-Latin] Organisms Affected

    Humans and other mammals